New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Shareholders have been substantially diluted in the past year (263% increase in shares outstanding). Revenue is less than US$1m (UK£15k revenue, or US$20k). Market cap is less than US$10m (UK£3.94m market cap, or US$5.33m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Reported Earnings • Oct 05
First half 2025 earnings released First half 2025 results: Net loss: UK£221.3k (loss widened UK£208.5k from 1H 2024). New Risk • Sep 30
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£649k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£649k free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Shareholders have been substantially diluted in the past year (263% increase in shares outstanding). Revenue is less than US$1m (UK£15k revenue, or US$20k). Market cap is less than US$10m (UK£4.44m market cap, or US$5.98m). Duyuru • Jul 15
Catenai PLC has filed a Follow-on Equity Offering. Catenai PLC has filed a Follow-on Equity Offering.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 157,142,857 Reported Earnings • Jun 30
Full year 2024 earnings released: EPS: UK£0 (vs UK£0.005 loss in FY 2023) Full year 2024 results: EPS: UK£0 (improved from UK£0.005 loss in FY 2023). Revenue: UK£131.5k (up 359% from FY 2023). Net loss: UK£128.2k (loss narrowed 51% from FY 2023). Duyuru • Jun 27
Catenai PLC has completed a Follow-on Equity Offering in the amount of £1.6 million. Catenai PLC has completed a Follow-on Equity Offering in the amount of £1.6 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 214,285,713
Price\Range: £0.0035
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 242,857,143
Price\Range: £0.0035
Transaction Features: Subsequent Direct Listing New Risk • May 14
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 144% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (65% average weekly change). Shareholders have been substantially diluted in the past year (144% increase in shares outstanding). Revenue is less than US$1m (UK£145k revenue, or US$192k). Market cap is less than US$10m (UK£3.27m market cap, or US$4.34m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Duyuru • May 12
Catenai PLC has completed a Follow-on Equity Offering in the amount of £0.75 million. Catenai PLC has completed a Follow-on Equity Offering in the amount of £0.75 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 500,000,000
Price\Range: £0.0015
Transaction Features: Subsequent Direct Listing Duyuru • Apr 18
Catenai PLC, Annual General Meeting, May 12, 2025 Catenai PLC, Annual General Meeting, May 12, 2025. Location: rwk goodman llp, 69 carter lane, london ec4v 5eq United Kingdom Duyuru • Apr 11
Catenai PLC has filed a Follow-on Equity Offering in the amount of £0.75 million. Catenai PLC has filed a Follow-on Equity Offering in the amount of £0.75 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 500,000,000
Price\Range: £0.0015
Transaction Features: Subsequent Direct Listing New Risk • Apr 08
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (UK£145k revenue, or US$184k). Market cap is less than US$10m (UK£710.2k market cap, or US$905.7k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). New Risk • Dec 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£346k free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (UK£145k revenue, or US$185k). Market cap is less than US$10m (UK£887.8k market cap, or US$1.13m). Reported Earnings • Sep 26
First half 2024 earnings released First half 2024 results: Net loss: UK£12.8k (flat on 1H 2023). Reported Earnings • Jun 30
Full year 2023 earnings released: UK£0.001 loss per share (vs UK£0.007 loss in FY 2022) Full year 2023 results: UK£0.001 loss per share (improved from UK£0.007 loss in FY 2022). Revenue: UK£28.7k (down 77% from FY 2022). Net loss: UK£261.3k (loss narrowed 37% from FY 2022). New Risk • Apr 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£126k). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (UK£122k revenue, or US$152k). Market cap is less than US$10m (UK£1.18m market cap, or US$1.47m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). New Risk • Mar 13
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 395% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£126k). Shareholders have been substantially diluted in the past year (395% increase in shares outstanding). Revenue is less than US$1m (UK£122k revenue, or US$156k). Market cap is less than US$10m (UK£988.3k market cap, or US$1.27m). Minor Risk Share price has been volatile over the past 3 months (10% average weekly change). Duyuru • Jan 17
Catenae Innovation Plc, Annual General Meeting, Feb 09, 2024 Catenae Innovation Plc, Annual General Meeting, Feb 09, 2024, at 12:00 Coordinated Universal Time. Location: 69 Carter Lane London United Kingdom New Risk • Jul 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£444k free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-UK£126k). Revenue is less than US$1m (UK£122k revenue, or US$157k). Market cap is less than US$10m (UK£470.3k market cap, or US$605.2k). Reported Earnings • Apr 02
Full year 2022 earnings released Full year 2022 results: UK£0.001 loss per share. Revenue: UK£122.0k (up 272% from FY 2021). Net loss: UK£411.8k (loss narrowed 63% from FY 2021). Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. CFO, Company Secretary & Executive Director John Farthing was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 30
First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021) First half 2022 results: EPS: UK£0 (in line with 1H 2021). Revenue: UK£17.5k (up 42% from 1H 2021). Net loss: UK£280.3k (loss narrowed 52% from 1H 2021). Board Change • Sep 30
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. CFO, Company Secretary & Executive Director John Farthing was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jul 19
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. CFO, Company Secretary & Executive Director John Farthing was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • May 05
Catenae Innovation Plc (AIM:CTEA) acquired 51% stake in Hyperneph Software Limited for £0.3 million. Catenae Innovation Plc (AIM:CTEA) acquired 51% stake in Hyperneph Software Limited for £0.3 million on April 4, 2021. Under the terms of the transaction, consideration for the acquisition amounts to £320,000, of which £270,000 will be satisfied in cash ("Cash Consideration") and the balance of £50,000 will be satisfied by way of the issue of new ordinary shares of Catenae Innovation ("Equity Consideration"). The Cash Consideration will be satisfied from Catenae's existing cash resources. The Equity Consideration will be satisfied by the issue of new ordinary shares on or around February 28, 2022 at the volume weighted average price of the Company's shares during the previous 10 trading days. Tony Sanders is a former director of the Company and a director and shareholder of Hyperneph. Alan Simpson, a former employee and current advisor to the Company, is a shareholder in Hyperneph. The new board of Hyperneph from completion of the acquisition will comprise Tony Sanders, Nick Delacamp and Michelle Guerney.Liam Murray and Jo Turner of Cairn Financial Advisers LLP acted as financial advisor for Catenae Innovation Plc.
Catenae Innovation Plc (AIM:CTEA) completed the acquisition of 51% stake in Hyperneph Software Limited on April 4, 2021. Duyuru • Nov 07
Catenae Innovation PLC Enters into Memorandum of Understanding with Afrik-ID (Pty) Ltd Catenae Innovation PLC announced that, further to the announcement made on 3 July 2020, following the completion of the four-month pilot agreement with Afrik-ID (Pty) Ltd. ("Afrik-ID"), the Company and Afrik-ID have entered into a Memorandum of Understanding ("MoU") to continue their relationship and work to commercialise potential opportunities. Of particular interest to Afrik-ID are the opportunities to utilise and leverage the services that can be supplied between Catenae and BHA-Medical Limited ("BHA-Medical") as announced by the Company on 16 October 2020. The MoU provides Afrik-ID with a framework to access to BHA-Medical's Covid-19 Near-Patient Healgen Antigen and the Three-Antibody test kits, as well as its professional clinical consultancy service to enable the tests to be conducted safely and successfully. Catenae's associated GDPR-compliant blockchain-based identity technology, including its data management platform and Onsite ID mobile app, could also be supplied to process the results. The services would be rolled out via Afrik-ID's network across sectors including construction, logistics, mining, sports, healthcare, human rights services, law-enforcement and travel and tourism. Its solutions would enable organisations, businesses and individuals to share certification and identity information via mobile phones in a secure manner. The MoU is not a legally binding agreement, there is no certainty that a definitive legal agreement will be entered into between the parties or that if such an agreement was entered into that it would generate profit for the Group. Duyuru • Jul 21
Catenae Innovation Plc Appoints Guy Meyer as Chief Executive Officer Catenae Innovation Plc announced Mr. Guy Meyer, Interim Chief Executive Officer, has taken on the role of Chief Executive Officer on a permanent basis with immediate effect. Duyuru • Jun 16
Catenae Innovation Plc has completed a Follow-on Equity Offering in the amount of £0.75 million. Catenae Innovation Plc has completed a Follow-on Equity Offering in the amount of £0.75 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 37,500,000
Price\Range: £0.02
Transaction Features: Subsequent Direct Listing 
